Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Dow
Julphar
UBS
Accenture
Daiichi Sankyo
Harvard Business School
Fish and Richardson

Generated: July 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018333

« Back to Dashboard

NDA 018333 describes CARAFATE, which is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from thirteen suppliers. Additional details are available on the CARAFATE profile page.

The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 018333
Tradename:CARAFATE
Applicant:Allergan Sales Llc
Ingredient:sucralfate
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018333
Medical Subject Heading (MeSH) Categories for 018333
Suppliers and Packaging for NDA: 018333
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARAFATE sucralfate TABLET;ORAL 018333 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-0780 N 0591-0780-01
CARAFATE sucralfate TABLET;ORAL 018333 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-0780 N 0591-0780-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Julphar
Fuji
AstraZeneca
Dow
Cantor Fitzgerald
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.